赛诺菲-安万特公司会在2025年1月29日公布下一份财报。

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those taking placebo treatment. Teva announced it was partnering with Sanofi to ...

The trial outcome could represent the “next frontier” in UC and CD treatment, Sanofi’s head of research and development, Houman Ashrafian, M.D., Ph.D., said in a statement.

17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Teva and Sanofi said last year they would collaborate on developing a ...

Gilead Sciences has raided Sanofi for its next chief medical officer, luring Dietmar Berger, M.D., Ph.D., away from the French drugmaker to replace Merdad Parsey, M.D ...

Aaron Siri — a lawyer with a history of seeking to expand exemptions to vaccines — asked the Food and Drug Administration to suspend or withdraw approval of Sanofi’s polio vaccine for ...

The primary endpoint, durable platelet response was observed in 23% of the therapy-treated adults. Credit: Volha_R/Shutterstock. Sanofi has reported that the Phase III LUNA 3 trial of rilzabrutinib ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Choline is a nutrient that supports important functions in ...

Let’s roll. An oral treatment developed by the French pharma giant Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder that causes the body ...

What is the most effective form of choline supplement for reducing fatty liver? Phosphatidylcholine has been shown to be one of the most effective forms of choline for reducing fatty liver.

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and ...

(RTTNews) - French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in Beijing, China, reports said. The move represents ...